Marc Antoine Aimé | Regen Lab

EWMA-GNEAUPP 2025

par Marc Antoine Aimé | Mar 10, 2025 | Congress

EWMA Congress 2025, Booth N68 | Monaco from 27, 28, 29 March 2025. We are delighted to announce that Regen Lab will be participating in the 35th Conference of the European Wound Management Association (EWMA), taking place from 26–28 March 2025 in Barcelona, Spain....

AMWC 2025

par Marc Antoine Aimé | Mar 4, 2025 | Uncategorized

AMWC Congress 2025, Booth N8 | Hall Ravel Monaco from 27, 28, 29 March 2025. Visit us Hall Ravel Booth N8 and discover how our regenerative solutions are transforming aesthetics and anti-ageing medicine. Let’s connect at our booth to discuss how Regen Lab is...

FEMALE SEXUAL DYSFUNCTION | Runels 2014

par Marc Antoine Aimé | Mar 3, 2025 | Clinical Study gynecology

FEMALE SEXUAL DYSFUNCTION Runels 2014 A Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction. Female sexual dysfunction may be manifested by decreases in sexual desire, arousal and...

STRESS URINARY INCONTINENCE | Long 2021

par Marc Antoine Aimé | Fév 17, 2025 | Clinical Study gynecology

STRESS URINARY INCONTINENCE Long 2021 A pilot study: effectiveness of local injection of autologous platelet-rich plasma in treating women with stress urinary incontinence. Stress urinary incontinence (SUI) is usually the result of the weakening of, or damage to, the...

Nordic Partnership

par Marc Antoine Aimé | Fév 12, 2025 | Corporate

SE | NO | DK : A New Era in Regenerative Medicine Distribution We are thrilled to announce the beginning of a new era in the distribution of Regen Lab products across Sweden, Norway, and Denmark. This exciting development is made possible through our esteemed...

« Entrées précédentes

Entrées suivantes »



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



Hyaluronic Acid

Coming Soon



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.